Diamonds and Dogs


BioNTech (BNTX) reports strong COVID-19 vaccine sales. German biotech stock is up 6% after easily beating estimates as sales rose 211% to $6.37 billion. BioNTech reiterated its outlook for 2022, including Covid vaccine revenue of €13 billion to €17 billion. The company also reiterated plans announced in March for a special cash dividend of €2.00, and stock buybacks of up to $1.5 billion over the next two years. BioNTech said it will continue to work with Pfizer on the next generation of Covid vaccines, including an Omicron-adapted candidate.

Not a good day for the markets. Electric truck and car maker, Rivian (RIVN) is down 19% as a lockup expires allowing companies like Ford, Amazon and others to sell millions of shares in the stock. Rivian only expects to produce 25,000 vehicles this year verse initial estimates of 50,000. The stock came public in November at around $100 a share, ran up to $179 a share to only crater 80%. A similar fate has occurred to   electric full-size pickup truck maker, Lordstown Motors (RIDE).

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.